Showing 3091-3100 of 4169 results for "".
- RealSelf: One-Third of US Adults Are Considering Cosmetic Treatmentshttps://modernaesthetics.com/news/realself-one-third-of-us-adults-are-considering-cosmetic-treatments/2471963/More than four in five U.S. adults want to improve their personal well-being or appearance in 2019, and 36 percent are considering cosmetic treatments, according to new RealSelf survey. Fully 82 percent of U.S. adults plan to make changes related to their personal well-being and/or appear
- #RealDealAesthetics Tackles Minimally Invasive Body Contouringhttps://modernaesthetics.com/news/realdealaesthetics-tackles-minimally-invasive-body-contouring/2471964/Save the date: Modern Aesthetics’® newest Tweet chat series -- #RealDealAesthetics -- featuring New York City dermatologist Gary Goldenberg, MD and Charleston, SC dermatologist Todd E. Schlesinger, MD is back. The first Tweet chat of 2019 focuses on minimally in
- AAFPRS Members Look Into Their Crystal Balls for the Year Aheadhttps://modernaesthetics.com/news/aafprs-members-look-into-their-crystal-balls-for-the-year-ahead/2471970/Facial plastic surgeons are taking out their crystal balls to share a glimpse of what we will see more, or less of, in the coming year in cosmetic surgery. Natural-looking results are here to stay. Gone, but not totally forgotten are the highly sculpted nose
- Merz Americas Rolls Out New Xeomin ‘Later Haters' Campaignhttps://modernaesthetics.com/news/merz-americas-rolls-out-new-xeomin-later-haters-campaign/2471983/Merz Americas is launching a new advertising campaign for Xeomin (incobotulinumtoxinA) called “Later Haters,” which urges women to “X out” judgment, stop apologizing for caring about how they look and put an end to feeling
- Bellus Recognized with Multiple Aesthetic Awardshttps://modernaesthetics.com/news/bellus-recognized-with-multiple-aesthetic-awards/2472006/Bellus Medical topped the charts in eight categories presented by the 2018 Aesthetic Everything® Awards: · Top Aesthetic Companies · Top Skin Care Devices (SkinPen&r
- NuEra Tight Radio Frequency Device Now Available from Lumenishttps://modernaesthetics.com/news/nuera-tight-radio-frequency-device-now-available-from-lumenis/2472008/Lumenis has launched NuEra tight, a non-invasive, intelligent temperature-controlled technology for both superficial and deep heating that treats a variety of conditions, such as skin
- BAAPS Calls for Brazilian Butt Lift Banhttps://modernaesthetics.com/news/baaps-calls-for-brazilian-butt-lift-ban/2472016/Due to the serious risks associated with the Brazilian butt lift, the British Association of Aesthetic Plastic Surgeons (BAAPS) is calling for a ban on the popular procedure until more data can be collected. The procedure is known to have the highest death rate of all cosmetic surger
- Introducing Juvéderm It, Allergan's Newest Ad Campaignhttps://modernaesthetics.com/news/introducing-juvderm-it-allergans-newest-ad-campaign/2472020/Allergan plc is rolling out a new Juvéderm advertising campaign that aims to make this family of fillers a household name. Comprising a modernized logo, a bright, poppy color scheme, an edgy soundtrack and robust social media component, Juvéderm It is the first new adv
- RealSelf: One in Three U.S. Adults are Considering Nips/Tuckshttps://modernaesthetics.com/news/realself-one-in-three-us-adults-are-considering-nipstucks/2472025/One in three adults (37 percent) in the U.S. are considering at least one cosmetic treatment in the next 12 months, with significantly more considering nonsurgical procedures (34 percent) than surgical ones (24 percent), according to the
- Allergan Acquires Bonti for $195Mhttps://modernaesthetics.com/news/allergan-acquires-bonti-for-195m/2472036/Allergan acquired Bonti, Inc., a privately held clinical-stage biotechnology company focused on the development and commercialization of novel, fast-acting neurotoxin programs for aesthetic and therapeutic applications. Following completion of the